Clinical Trial Update: Temocillin Versus a Carbapenem as Initial Intravenous Treatment for ESBL Related Urinary Tract Infections [Phase 3]

View source ↗

Summary

Phase 3 trial comparing temocillin with a carbapenem as initial intravenous treatment for ESBL-related urinary tract infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Carbapenem (carbapenem)
• Temocillin (temocillin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Urinary Tract Infections | Phase 3 | Status: COMPLETED